Fiber

Common Nutrition Mistakes on a GLP-1

Written by Golp Editorial Team Sourced from FDA, USDA, NIH, and peer-reviewed US research Updated August 2026 1 min read

Short answer

The most commonly flagged nutrition risks during GLP-1 therapy, per a joint US clinical advisory, are inadequate protein intake, unmanaged nutrient gaps, and not addressing digestive side effects through food choices. None of these are unusual to run into, they're just easy to miss without paying attention.

Why it matters

These aren't exotic risks, they're the direct, well-documented result of eating meaningfully less overall. Knowing what to watch for makes them easier to catch early.

What the evidence says

The joint advisory published in the American Journal of Clinical Nutrition identifies nutrient deficiency prevention, muscle and bone mass preservation, and gastrointestinal side effect management as key clinical priorities during GLP-1 therapy, implying these are the areas most likely to be overlooked without intentional attention.

The golp take

None of this is about doing everything perfectly. It's about knowing the two or three things worth paying attention to, so smaller meals don't quietly turn into gaps you don't notice for months.

What to do

  • Don't let smaller meals mean lower-quality meals, prioritize protein and fiber within whatever volume you're eating
  • Don't ignore persistent digestive side effects, the advisory frames these as manageable through food choices, worth discussing with a provider
  • Don't skip resistance training if muscle preservation is a concern, diet alone isn't the full picture per the advisory
  • Don't assume your nutrition needs are the same as when you were eating more
A bottle of golp Fiber Gummies, strawberry flavor, with a pink cap and a pink label featuring the brand name 'golp' in large white letters. The bottle is filled with pink gummies and is set against a clean, light gray gradient background.

Featured product

DAILY FIBER GUMMIES

$39.99

Shop DAILY FIBER GUMMIES

Related questions

Sources

  1. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from ACLM, ASN, OMA, and TOS. Am J Clin Nutr. 2025;122(2):344-367.

FAQs

Is muscle loss inevitable on a GLP-1?

The advisory addresses it as a risk to actively manage through diet and resistance training, not treated as unavoidable.

How do I know if I have a nutrient gap?

A healthcare provider can assess this, sometimes through bloodwork; it's not something to self-diagnose.

Is this different for people not on a GLP-1?

These priorities are addressed in the advisory specifically in the context of GLP-1 therapy, given the appetite and intake changes involved.